Trevi Therapeutics, Inc. (TRVI)
16.61
-0.21
(-1.25%)
USD |
NASDAQ |
Sep 09, 15:01
Trevi Therapeutics 1 Year Total Returns (Daily) : 121.3% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | 121.3% |
| September 04, 2026 | 138.7% |
| September 03, 2026 | 138.6% |
| September 02, 2026 | 134.5% |
| September 01, 2026 | 128.4% |
| August 31, 2026 | 128.8% |
| August 28, 2026 | 132.9% |
| August 27, 2026 | 124.5% |
| August 26, 2026 | 141.5% |
| August 25, 2026 | 146.6% |
| August 24, 2026 | 139.5% |
| August 21, 2026 | 139.8% |
| August 20, 2026 | 146.0% |
| August 19, 2026 | 157.0% |
| August 18, 2026 | 152.9% |
| August 17, 2026 | 145.7% |
| August 14, 2026 | 146.5% |
| August 13, 2026 | 138.8% |
| August 12, 2026 | 141.9% |
| August 11, 2026 | 143.0% |
| August 10, 2026 | 139.9% |
| August 07, 2026 | 153.6% |
| August 06, 2026 | 154.5% |
| August 05, 2026 | 151.7% |
| August 04, 2026 | 150.3% |
| Date | Value |
|---|---|
| August 03, 2026 | 144.2% |
| July 31, 2026 | 146.5% |
| July 30, 2026 | 148.0% |
| July 29, 2026 | 139.6% |
| July 28, 2026 | 141.2% |
| July 27, 2026 | 130.2% |
| July 24, 2026 | 123.7% |
| July 23, 2026 | 117.7% |
| July 22, 2026 | 148.0% |
| July 21, 2026 | 166.6% |
| July 20, 2026 | 144.5% |
| July 17, 2026 | 178.8% |
| July 16, 2026 | 158.7% |
| July 15, 2026 | 164.5% |
| July 14, 2026 | 155.5% |
| July 13, 2026 | 152.2% |
| July 10, 2026 | 178.3% |
| July 09, 2026 | 198.2% |
| July 08, 2026 | 217.5% |
| July 07, 2026 | 227.7% |
| July 06, 2026 | 201.7% |
| July 02, 2026 | 199.8% |
| July 01, 2026 | 208.9% |
| June 30, 2026 | 241.0% |
| June 29, 2026 | 231.5% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ANI Pharmaceuticals, Inc. | -26.23% |
| Corcept Therapeutics, Inc. | 60.02% |
| Veru, Inc. | -23.44% |
| Johnson & Johnson | 54.48% |
| Eli Lilly & Co. | 53.12% |